ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 73–84 of 220 project topics
Real-Time Immune Checkpoint Expression Analysis Service
A diagnostic testing service platform that quantifies PD-L1, LAG-3, TIM-3, and emerging checkpoint markers on circulating and tissue-resident immune cells. Delivers revenue through per-sample processing fees while enabling oncologists to predict immunotherapy response and optimize combination therapies.
Molecular Oncology Immunotherapy Development Click to view more details →
Immunotherapy Biomarker Database and Matching Algorithm
Enterprise software that aggregates multi-omics biomarker data and matches patients to optimal immunotherapy candidates using predictive analytics. Generates B2B revenue through licensing agreements with hospital networks and clinical trial sponsors seeking precision patient matching.
Molecular Oncology Immunotherapy Development Click to view more details →
CAR-T Cell Engineering Optimization and Design Platform
A computational design tool that optimizes CAR construct architecture, costimulatory domain combinations, and manufacturing parameters using machine learning. Enables cell therapy companies to improve potency, reduce off-target toxicity, and accelerate regulatory submissions while commanding premium software licensing fees.
Molecular Oncology Immunotherapy Development Click to view more details →
Immunotherapy Drug Combination Efficacy Prediction Software
A proprietary analytics platform that models synergistic interactions between checkpoint inhibitors, cytokines, targeted agents, and conventional therapeutics using patient-derived data. Supports pharma companies in de-risking combination clinical trials and securing combination indication approvals worth billions in additional revenue.
Molecular Oncology Immunotherapy Development Click to view more details →
Immune Profiling Contract Research Service Network
A managed services offering that provides comprehensive immune phenotyping, TCR/BCR sequencing, and immunofunctional assays on clinical samples using standardized protocols. Delivers recurring revenue to biotech and pharma clients through service contracts while building proprietary databases for predictive model development.
Molecular Oncology Immunotherapy Development Click to view more details →
Patient Immune Response Monitoring and Real-World Evidence Platform
A digital health platform that tracks immune cell dynamics and clinical outcomes in post-market immunotherapy patients through blood biomarker analysis and mobile health integration. Generates revenue through data licensing to pharmaceutical companies seeking real-world evidence and adaptive trial insights.
Molecular Oncology Immunotherapy Development Click to view more details →
Tumor-Infiltrating Lymphocyte Expansion Optimization Technology
An automated bioprocess design and monitoring platform that optimizes ex vivo TIL expansion culture conditions and predicts manufacturing success using real-time analytics. Provides equipment, consumables, and software licensing revenue while reducing cell therapy manufacturing costs and time-to-patient.
Molecular Oncology Immunotherapy Development Click to view more details →
Immunotherapy Safety and Toxicity Risk Prediction System
Machine learning software that forecasts immune-related adverse event probability and severity using baseline immune profiling and genomic data. Helps clinical trial sponsors de-risk patient enrollment and supports pharma companies in optimizing benefit-risk profiles for regulatory approval and market adoption.
Molecular Oncology Immunotherapy Development Click to view more details →
Tumor Mutation Profiling SaaS Platform for Precision Oncology
A cloud-based software platform that analyzes genomic sequencing data to identify tumor-specific mutations and generate comprehensive molecular profiles for clinical decision-making. This service enables pharmaceutical companies and hospitals to monetize precision medicine workflows through subscription-based access and per-sample analysis fees.
Molecular Oncology CRO Service Platforms Click to view more details →
Real-time Biomarker Discovery and Validation Service Suite
An integrated commercial service offering rapid identification and clinical validation of predictive biomarkers for cancer patient stratification and treatment selection. This platform generates revenue through tiered licensing models, consultation services, and partnerships with pharmaceutical companies developing targeted cancer therapies.
Molecular Oncology CRO Service Platforms Click to view more details →
Drug Response Prediction Engine Using Patient Tumor Data
A proprietary artificial intelligence platform that predicts individual patient responses to oncology drugs based on molecular tumor characteristics and clinical data integration. The platform captures revenue through licensing agreements with hospitals, cancer centers, and pharmaceutical companies conducting clinical trials.
Molecular Oncology CRO Service Platforms Click to view more details →
Immunotherapy Candidate Identification and Matching Platform
A commercial analytics tool that identifies cancer patients most likely to respond to immunotherapy based on tumor microenvironment analysis and immune checkpoint biomarkers. This service creates recurring revenue streams through hospital partnerships, insurance reimbursement models, and pharmaceutical sponsor fees.
Molecular Oncology CRO Service Platforms Click to view more details →